Reuters  11 hrs ago  Comment 
Novartis expects a more difficult pricing environment for drugs in the United States in the years ahead, its chief executive told a results conference call on Tuesday.
Reuters  Oct 25  Comment 
* Q3 sales down 1 pct at $12.1 bln, lagging poll (Recasts, adds CEO comment, analysts, background)
FiercePharma  Oct 25  Comment 
UPDATED: Novartis slows Gleevec bleeding to manage Q3 beats amid Alcon's downward spiral chelfand Tue, 10/25/2016 - 04:23
Wall Street Journal  Oct 25  Comment 
Novartis’s third-quarter net income grew thanks to proceeds from its consumer health venture with GlaxoSmithKline, helping to offset declining revenue and heavy investment in its new heart-failure medicine and its ailing eye-care unit.
newratings.com  Oct 25  Comment 
BASEL (dpa-AFX) - Novartis (NVS) reported third-quarter net income from continuing operations of $1.9 billion, an increase of 7% year-over-year, up more than operating income mainly due to higher income from associated companies. EPS was $0.81...
newratings.com  Oct 25  Comment 
Novartis delivered solid third quarter with Growth Products[1] offsetting Gleevec patent expiration; several positive readouts for potential blockbusters Novartis International AG / Novartis delivered solid third quarter with Growth Products[1]...
FiercePharma  Oct 24  Comment 
With no big M&A on tap, Novartis presses pause on $12B-plus Roche stake sale: Sonntagszeitung tracy Mon, 10/24/2016 - 11:25


Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki